Market Research Logo

CHA Bio & Diostech Co., Ltd. - Product Pipeline Review - 2015

CHA Bio & Diostech Co., Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘CHA Bio & Diostech Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the CHA Bio & Diostech Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of CHA Bio & Diostech Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of CHA Bio & Diostech Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of CHA Bio & Diostech Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the CHA Bio & Diostech Co., Ltd.’s pipeline products
Reasons to buy
  • Evaluate CHA Bio & Diostech Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of CHA Bio & Diostech Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the CHA Bio & Diostech Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of CHA Bio & Diostech Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of CHA Bio & Diostech Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of CHA Bio & Diostech Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


CHA Bio & Diostech Co., Ltd. Snapshot
CHA Bio & Diostech Co., Ltd. Overview
Key Information
Key Facts
CHA Bio & Diostech Co., Ltd. - Research and Development Overview
Key Therapeutic Areas
CHA Bio & Diostech Co., Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
CHA Bio & Diostech Co., Ltd. - Pipeline Products Glance
CHA Bio & Diostech Co., Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
CHA Bio & Diostech Co., Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
CHA Bio & Diostech Co., Ltd. - Drug Profiles
PLX-PAD
Product Description
Mechanism of Action
R&D Progress
MA09-hRPE
Product Description
Mechanism of Action
R&D Progress
Placenta Derived Mesenchymal Stem Cell Therapy for Alzheimer's Disease
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for CNS Disorders
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Cardivascular Diseases and Foot Ulcer
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Cerebral Palsy
Product Description
Mechanism of Action
R&D Progress
CHA Bio & Diostech Co., Ltd. - Pipeline Analysis
CHA Bio & Diostech Co., Ltd. - Pipeline Products by Route of Administration
CHA Bio & Diostech Co., Ltd. - Pipeline Products by Molecule Type
CHA Bio & Diostech Co., Ltd. - Recent Pipeline Updates
CHA Bio & Diostech Co., Ltd. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
CHA Bio & Diostech Co., Ltd., Key Information
CHA Bio & Diostech Co., Ltd., Key Facts
CHA Bio & Diostech Co., Ltd. - Pipeline by Indication, 2015
CHA Bio & Diostech Co., Ltd. - Pipeline by Stage of Development, 2015
CHA Bio & Diostech Co., Ltd. - Monotherapy Products in Pipeline, 2015
CHA Bio & Diostech Co., Ltd. - Partnered Products in Pipeline, 2015
CHA Bio & Diostech Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015
CHA Bio & Diostech Co., Ltd. - Phase II, 2015
CHA Bio & Diostech Co., Ltd. - Phase I, 2015
CHA Bio & Diostech Co., Ltd. - Preclinical, 2015
CHA Bio & Diostech Co., Ltd. - Discovery, 2015
CHA Bio & Diostech Co., Ltd. - Pipeline by Route of Administration, 2015
CHA Bio & Diostech Co., Ltd. - Pipeline by Molecule Type, 2015
CHA Bio & Diostech Co., Ltd. - Recent Pipeline Updates, 2015
List of Figures
CHA Bio & Diostech Co., Ltd. - Pipeline by Top 10 Indication, 2015
CHA Bio & Diostech Co., Ltd. - Pipeline by Stage of Development, 2015
CHA Bio & Diostech Co., Ltd. - Monotherapy Products in Pipeline, 2015
CHA Bio & Diostech Co., Ltd. - Partnered Products in Pipeline, 2015
CHA Bio & Diostech Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015
CHA Bio & Diostech Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report